bladder cancer
Conditions
Interventions
Treatment group:N/A
Sponsors
The First Affiliated Hospital of Navy Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) The patient was over 18 years old; (2) Bladder urothelial carcinoma was confirmed by cystoscopy and pathological biopsy before surgery. (3) medium-high risk NMIBC patients receiving BCG vaccine; (4) Sign the informed consent of the enrolled clinical trial
Exclusion criteria
Exclusion criteria: (1) Unwilling to sign informed consent; (2) Non-urothelial carcinoma such as squamous cell carcinoma of the bladder and adenocarcinoma of the bladder was confirmed by preoperative cystoscopy biopsy; (3) Unable to understand the study process and unwilling to follow up after surgery; (4) patients with gross hematuria; (5) symptomatic urinary tract infection; (6) patients with active tuberculosis; (7) Patients taking immunosuppressants or immunocompromised; (8) Preoperative neoadjuvant chemotherapy; (9) Postoperative systemic chemotherapy and postoperative radiotherapy; (10) Complicated with heart, liver, kidney and other organ dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutrophil to lymphocyte ratio;Recurrence rate of bladder cancer; | — |
Countries
China
Contacts
Public Contactzhangzhensheng
The First Affiliated Hospital of Navy Medical University
Outcome results
None listed